SPOTLIGHT: Stem cell therapy for bones nearing human trials

An Edinburgh University team of researchers has been using a bioactive scaffold to help spur stem cells to grow into bone or cartilage. The researchers say the approach can be tested in humans in two years for severe trauma. Report

Suggested Articles

Zydus Cadila has completed a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 .

OrbiMed, Novartis Venture Fund and RA Capital Management have joined forces to fund and help launch GentiBio.

A month after scoring $1.6 billion from the U.S. government, Novavax is posting the first human data from its COVID-19 vaccine.